Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

17.32
-0.9200-5.04%
Post-market: 17.450.1300+0.75%19:57 EDT
Volume:4.16M
Turnover:73.03M
Market Cap:1.70B
PE:-6.69
High:18.27
Open:18.03
Low:17.31
Close:18.24
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Charles River, Emerson Electric, Honeywell

Reuters
·
07 May

Sarepta Therapeutics, Inc. : Deutsche Bank Cuts Target Price to $50 From $70

THOMSON REUTERS
·
07 May

Sarepta Therapeutics Inc : Morgan Stanley Cuts Target Price to $113 From $182

THOMSON REUTERS
·
07 May

Sarepta price target lowered to $89 from $209 at Barclays

TIPRANKS
·
07 May

Sarepta Therapeutics Shares Fall 17.6% Premarket After Co Lowers FY Product Revenue Forecast

THOMSON REUTERS
·
07 May

Stock Track | Sarepta Therapeutics Plunges 18.72% Pre-market on Q1 Loss, Lowered Guidance, and FDA Concerns

Stock Track
·
07 May

Barclays Keeps Their Buy Rating on Sarepta Therapeutics (SRPT)

TIPRANKS
·
07 May

Sarepta Therapeutics Inc : Piper Sandler Cuts Target Price to $70 From $110

THOMSON REUTERS
·
07 May

Sarepta Therapeutics Inc : Jefferies Cuts Target Price to $125 From $165

THOMSON REUTERS
·
07 May

Stock Track | Sarepta Therapeutics Plunges 21% on FDA Appointment and Lowered Revenue Guidance

Stock Track
·
07 May

Stocks to Watch: Super Micro Computer, Electronic Arts, WW International, Sarepta Therapeutics

Dow Jones
·
07 May

Sarepta Therapeutics Shares Fall on Full-Year Outlook Cut, Swing to 1Q Loss

Dow Jones
·
07 May

BUZZ-Sarepta sinks after lowering 2025 product revenue forecast

Reuters
·
07 May

Sarepta Therapeutics Stock Plummets After Q1 Results: Here's Why

Benzinga
·
07 May

Sarepta Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Small U.S. Stocks Drop; Sarepta Therapeutics Takes Biggest Hit

Dow Jones
·
07 May

Shares of Sarepta Therap Down 20% in Extended Trade After Quarterly Report

THOMSON REUTERS
·
07 May

Sarepta Therapeutics Q1 Adj. EPS $(3.42) Misses $(0.95) Estimate, Sales $744.86M Beat $683.36M Estimate

Benzinga
·
07 May

Sarepta Therapeutics Inc: Revises 2025 Total Net Product Revenues Guidance to $2.3 Bln to $2.6 Bln

THOMSON REUTERS
·
07 May

BUZZ-Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official

Reuters
·
07 May